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Abstract 
Transcriptome wide changes in human skeletal muscle after acute (anabolic) and chronic resistance exercise 
(RE) induced hypertrophy have been extensively determined in the literature. We have also recently 
undertaken DNA methylome analysis (850,000 + CpG sites) in human skeletal muscle after acute and 
chronic RE, detaining and retraining, where we identified a role for DNA methylation in an epigenetic 
memory of exercise induced skeletal muscle hypertrophy. However, it is currently unknown as to whether 
all the genes identified in the transcriptome studies to date are also epigenetically regulated at the DNA level 
after acute, chronic or repeated RE exposure. We therefore aimed to undertake large scale bioinformatical 
analysis by pooling the publicly available transcriptome data after acute (110 samples) and chronic RE (181 
samples) and comparing these large data sets with our genome-wide DNA methylation analysis in human 
skeletal muscle after acute and chronic RE, detraining and retraining. Indeed, after acute RE we identified 
866 up- and 936 down-regulated genes at the expression level, with 270 (out of the 866 up-regulated) 
identified as being hypomethylated, and 216 (out of 936 downregulated) as hypermethylated. After chronic 
RE we identified 2,018 up- and 430 down-regulated genes with 592 (out of 2,018 upregulated) identified as 
being hypomethylated and 98 (out of 430 genes downregulated) as hypermethylated. After KEGG pathway 
analysis, genes associated with ‘cancer’ pathways were significantly enriched in both bioinformatic analysis 
of the pooled transcriptome and methylome data after both acute and chronic RE. This resulted in 23 (out of 
69) and 28 (out of 49) upregulated and hypomethylated and 12 (out of 37) and 2 (out of 4) downregulated 
and hypermethylated ‘cancer’ genes following acute and chronic RE respectively. Within skeletal muscle 
tissue, these ‘cancer’ genes predominant functions were associated with matrix/ actin structure and 
remodelling, mechano-transduction (including PTK2/Focal Adhesion Kinase and Phospholipase D- 
following chronic RE only), TGF-beta signalling and protein synthesis (GSK3B after acute RE only). 
Interestingly, 51 genes were also identified to be up/downregulated in both the acute and chronic RE pooled 
transcriptome analysis as well as significantly hypo/hypermethylated after acute RE, chronic RE, detraining 
and retraining. Five genes; FLNB, MYH9, SRGAP1, SRGN, ZMIZ1 demonstrated increased gene 
expression in the acute and chronic RE transcriptome and also demonstrated hypomethylation in these 
conditions. Importantly, these 5 genes demonstrated retained hypomethylation even during detraining 
(following training induced hypertrophy) when exercise was ceased and lean mass returned to baseline (pre-
training) levels, identifying them as novel epigenetic memory genes. Importantly, for the first time across 
the transcriptome and epigenome combined, this study identifies novel differentially methylated genes 
associated with human skeletal muscle anabolism, hypertrophy and epigenetic memory.  
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Introduction 
Skeletal muscle tissue demonstrates extensive plasticity, responding dynamically to sustained mechanical 
loading and contraction with muscle hypertrophy. However, skeletal muscle tissue also wastes (atrophy) 
rapidly during periods of disuse, for example, following an injury from a fall or reduces in size overtime as a 
result of ageing (sarcopenia, reviewed in 1,2). The transcriptome wide changes in gene expression that 
regulate healthy adult human skeletal muscle anabolism and hypertrophy in response to acute and chronic 
resistance exercise (RE) respectively have been reported in the literature 3-10. Ultimately, the identification 
of genes associated with skeletal muscle mass regulation continue to progress this field of research in order 
to optimise the growth response to resistance exercise and help prevent muscle wasting. Despite these recent 
advances, it is currently unknown as to whether the genes identified at the mRNA level across the 
transcriptome are also epigenetically regulated at the DNA level.  
 
Epigenetics is the study of DNA that is modified as a result of an encounter with the environment. These 
DNA modifications subsequently affect genes at the transcript level. The major forms of DNA modification 
include alterations to the surrounding histones as a result of methylation, acetylation and deacetylation. 
Histone modifications lead to the DNA being rendered into a repressive (inhibitory) or permissive 
(allowing) state, that subsequently alters access for the transcriptional machinery regulating gene expression. 
DNA itself can also be modified directly by methylation, via the addition or removal of methyl groups, 
particularly to cytosine-guanine base pairing (CpG) sites. For example, increased DNA methylation 
(hypermethylation) that occurs in the fifth position of a cytosine (5mC) residue of a CpG site, particularly if 
present in the promoter or enhancer region of a gene, can attenuate the performance of transcriptional 
apparatus and can cause a reduction in the expression of a specific gene 11. On the other hand, a reduction in 
DNA methylation (hypomethylation) can improve the function of transcription factors and therefore 
enhance gene expression 11.  
 
We have recently characterised genome-wide DNA methylation of over 850,000 CpG sites across the 
human genome in skeletal muscle at rest (baseline), after acute resistance exercise (acute RE), chronic 
resistance exercise induced hypertrophy (training/loading), followed by a period of detaining (where muscle 
returned to baseline- termed unloading), and finally after retraining induced hypertrophy 
(retraining/reloading)12. Therefore, in the present study we aimed to identify if transcriptome wide gene 
expression changes were associated with DNA methylation of the same genes across the genome 
(methylome) after acute and chronic RE. In order to achieve this aim, we undertook large scale 
bioinformatical analysis that pooled the publicly available transcriptome data sets from human skeletal 
muscle pre/post-acute (110 gene array samples) and chronic (181 gene array samples) resistance exercise 
and overlapped this with the genome-wide DNA methylation after acute and chronic resistance exercise 
from our recent study 12.  
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Finally, we have recently demonstrated that skeletal muscle has an epigenetic memory 12,13. Where, DNA 
methylation signatures (particularly hypomethylation) were retained even when exercise ceased during 
detraining (and lean mass was returned to pre-exercise levels) following chronic RE induced hypertrophy in 
humans, leading to an advantageous state for these genes to be further upregulated when later retaining 
induced hypertrophy was encountered 12. However, in this study we did not perform transcriptome wide 
gene expression analyses, opting instead for targeted gene expression analysis of those genes that mapped to 
the most significantly regulated CpG sites. Therefore, the secondary aim of the present study was to identify 
if transcriptome wide gene expression changes from pooled publicly available data sets after acute and 
chronic RE, were associated with the methylome changes seen during training, detraining and retaining in 
our epigenetic muscle memory studies.  
 
Overall, we hypothesised that we would identify new epigenetically regulated genes and gene pathways in 
human skeletal muscle anabolism, hypertrophy and those associated with epigenetic muscle memory. We 
also hypothesised that transcriptome wide changes identified in the pooled transcriptome analysis after acute 
and chronic RE would be associated with altered DNA methylation of some of the same genes after training, 
detraining and retraining.  
 
Methods 
Identification of transcriptomic studies  
The studies used for pooled transcriptome analysis for both acute and chronic resistance exercise (RE) are 
summarised in Suppl. File 1. These include publicly available transcriptome data sets deposited and 
searchable before the end of April 2018. In order to enable a suitable comparison of the transcriptomic 
studies after acute and chronic RE in humans we incorporated the following inclusion and exclusion criteria 
in our search. For acute RE, we included all transcriptome array data from the skeletal muscle of young 
healthy adult males in order to enable the comparison with the genome-wide DNA methylation analysis that 
was undertaken in the same population in 12. Resistance exercise intensity was not an exclusion criterion per 
se, however no aerobic, continuous or concurrent exercise studies were included. All time points of isolated 
RNA from biopsies that were within the first 24 hrs post an acute bout of RE were included, and samples 
taken after 24 hrs were excluded. Due to the varied time points at which RNA was sampled following acute 
RE, with only a small number of studies sampling at the same timepoint, all samples taken immediately post 
exercise and up to 24 hrs were attributed to the same post-acute RE biopsy condition for the pooled 
transcriptome analysis. Furthermore, within studies, if there were multiple time points of biopsy sampling, 
all times points were included up to 24 hrs and attributed within the same post-acute RE biopsy condition 
for the analysis. We excluded any study with less than 10,000 gene probe-sets annotated by ‘gene symbol’. 
These studies used earlier gene array platforms with a low number of gene transcripts analysed versus more 
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recent data sets with approximately 20,000 or more gene transcripts. When including the studies with 10,000 
probe-sets or less, this dramatically affected the number of the same genes that were assessed between 
studies and meant that we could not accurately compare any of the larger more recent studies that used the 
latest gene array platforms. For chronic RE transcriptome data, we included young heathy adult males both 
pre and post chronic RE with biopsies taken at rest. There was no set frequency, duration or intensity of RE- 
although minimum frequency and duration for the chronic RE studies was 12 weeks resistance exercise 2 
times per week (detailed in Suppl. File 1). As in the acute analysis above, we excluded probe sets below 
10,000 annotated genes by ‘gene symbol.’ A table of all studies can be found in Suppl. File 1. 
 
Bioinformatic Pooled Transcriptome Analysis 
All available data sets were downloaded from NIH data base, Gene Expression Omnibus (GEO), website 
and imported into Partek Genomics Suite software (version 7.18.0518, Partek Inc. Missouri, USA) as .CEL 
or .TXT files for both acute and chronic RE studies independently. The relevant gene array platform 
annotation file, also downloaded from GEO, was then assigned to the appropriate data set. For the majority 
of the data sets, it was stated on GEO, that samples were normalised via the Robust Multi-array 
Average (RMA) method (that includes Log2 transformation) upon import. If data were normalised but not 
Log2 transformed (for example if data was MAS5 normalised upon import), these were subsequently Log2 
transformed. For genes that were detected by more than one probe set we selected the highest-scoring probe 
set to represent that gene in order to allow a comparison of the unambiguous expression estimate of an 
individual gene, and compare it across studies/array platforms. This has previously been defined as a 
relevant method to account for altered hybridisation efficiency across multiple probe sets for the same gene 
and across array platforms 14,15. To be able to directly compare gene expression between studies, we then 
identified a list of the common gene symbol annotations across all studies. This allowed us to filter each 
individual data set by gene symbols that were uniformly shared across the different array platforms, 
subsequently allowing comparison of identical genes across all included studies. All filtered acute RE or 
chronic RE data sets were then merged together and samples that did not satisfy the inclusion/exclusion 
criteria described above, were removed. Sample attributes were then defined as ‘pre’ or ‘post’ acute RE and 
‘pre’ or ‘post’ chronic RE, also in line with the inclusion/exclusion criteria stated above. Quality assurance 
(QA) and control (QC) analyses were undertaken on both the acute and chronic study data sets 
independently. Principal component analysis, box/whisker charts and sample frequency/density plots by 
lines were produced for both the merged acute RE and chronic RE data sets. Samples were then excluded 
via PCA analysis if they deviated 2 standard deviations from the mean values of the group (using ellipsoids- 
see figures/legends for details) for the time attribute (pre or post) or within each study. To correct for 
differences in processing methods of the samples across studies, we performed batch correction using Partek 
Genomics Suite ‘Remove Batch Effects’ tool, previously reported as an appropriate batch correction tool 
when dealing with data of non-trivial size (i.e. several samples per condition 16,17). Specific and detailed 
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description of QA/QC and batch removal can be seen in the appropriate figure legends. Detection of 
differentially expressed genes was then performed on Partek using an ANOVA for both acute and chronic 
RE (Pre vs. Post contrast) (version 7.18.0518) and a gene list of all the significantly (P ≤ 0.01) differentially 
regulated genes (both up and down) was created.  
 
Overlapping of Pooled Transcriptome Analysis with the DNA Methylome 
Using Venn diagram analysis, the significant differentially regulated gene lists generated from the pooled 
transcriptomic gene expression analysis described above were overlapped with the significantly 
differentially modified CpG sites lists from the freely available supplementary files of 12, after both acute RE 
and chronic RE (latter termed ‘loading’ in the original article), detraining (unloading) and retaining 
(reloading). Genome-wide DNA methylation data were therefore processed as previously defined in the 
original data 12 and a recently published data descriptor for the original study 18. Briefly, raw .IDAT files 
were processed on Partek Genomic Suite V.6.6 (Partek Inc. Missouri, USA) and background normalisation 
was performed via the Subset-Quantile Within Array Normalisation (SWAN) method 19 and imported using 
the MethylationEPIC_v-1-0_B2.bpm manifest file. This analysis enabled us to compare genes that were 
both up/downregulated at the expression level and hypo/hypermethylated at the DNA level after both acute 
and chronic RE. It also allowed us to associate genes that were up/down regulated in the comparative 
transcriptome analysis after acute and chronic RE that were hypo/hypermethylated at the DNA level after 
acute RE, training, detaining and retaining.  
 
Pathway Analysis 
Using statistically generated gene expression and CpG data (detailed above), KEGG signalling pathway 
analysis 20-22 (see results/figures for significance level of enrichment P values) was performed in Partek 
Genomic Suite and Partek Pathway.  
 
Target Gene Expression of FLNB by rt-qRT-PCR 
Human skeletal muscle RNA previously derived in 12 was reanalysed and used in the present study. The 
RNA was originally isolated from biopsies taken from the vastus lateralis of young adult males. Participant 
characteristics, full biopsy and RNA isolation procedures are described in 12,18. RNA from baseline, 30 
minutes post-acute resistance exercise (acute RE), 7 weeks training (loading), 7 weeks detraining 
(unloading) and 7 weeks retraining (reloading) was used for rt-qRT-PCR using QuantiFastTM SYBR® 
Green RT-PCR one-step kit on a Rotorgene 3000Q, with a reaction setup as follows; 4.75 μl experimental 
sample (7.36 ng/μl totalling 35 ng per reaction), 0.075 μl of both forward and reverse primer of the gene of 
interest (100 μM stock suspension), 0.1 μl of QuantiFast RT Mix (Qiagen, Manchester, UK) and 5 μl of 
QuantiFast SYBR Green RT-PCR Master Mix (Qiagen, Manchester, UK). Reverse transcription initiated 
with a hold at 50oC for 10 minutes (cDNA synthesis) and a 5 minute hold at 95oC (transcriptase inactivation 
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and initial denaturation), before 40-45 PCR cycles of; 95oC for 10 sec (denaturation) followed by 60oC for 
30 secs (annealing and extension). Primer sequence for gene of interest, Filamin B (FLNB), was designed to 
detect/span all FLNB transcript variants 1, 2, 3, 4 and X1 (NM_001164317.1, NM_001457.3, 
NM_001164318.1, NM_001164319.1 and XM_005264978.2 respectively) as a global measure of FLNB 
gene expression. Primer sequences for the gene of interest, FLNB were: F: 
GTGGACACCAGCAGGATCAA; R: CGGCCGAGAGTCAACTGTAA, product length 96 bp) and 
reference gene, RPL13a (NM_012423) were: F: GGCTAAACAGGTACTGCTGGG; R: 
AGGAAAGCCAGGTACTTCAACTT, product length 105 bp. Both FLNB and RPL13a primer sequences 
demonstrated no unintended targets via BLAST search and yielded a single peak after melt curve analysis 
conducted after the PCR step above. All relative gene expression was quantified using the comparative Ct 
(∆∆Ct) method 23. Individual participants own baseline (pre) Ct values were used in ∆∆Ct equation as the 
calibrator, using RPL13a as the reference gene, except for one of the participants where there was no 
baseline/pre RNA remaining from the original study12. Therefore, a pooled baseline/pre-value of all 
participants was used to generate fold changes in all other experimental conditions for this particular 
participant. Indeed, the pooled baseline samples for FLNB across all participants demonstrated a small 
variation in Ct value 25.59 (± 0.87 SDEV, 3.4% variation). The average Ct value for the reference gene 
RPL13a was also consistent across all participants and experimental conditions (22.04 ± 0.52, SDEV) with 
small variation of 2.3%. The average PCR efficiencies of FLNB (95.83%) were comparable with the 
reference gene RPL13a (97.07%).  
 
Results 
Pooled Transcriptome Analysis overlapped with the Methylome in Human Skeletal Muscle after Acute 
Resistance Exercise 
In total, 110 gene arrays from skeletal muscle biopsies were used for pooled transcriptome analysis, 
including: 41 baseline (pre) samples and 69 post-acute resistance exercise (RE) samples (37 pre / 57 post 
after outlier removal). These studies shared 14,992 annotated genes by ‘gene symbol’ (Figure 1A). Relevant 
QA/QC and outlier removal is depicted and described in Figure 1B-I and detailed in the associated figure 
legend. Downstream differential gene expression analysis of the transcriptome data across all 5 studies 
demonstrated that there were 1,802 genes significantly differentially regulated (P ≤ 0.01) after acute RE 
(Full List Suppl. File 2A). Out of these genes, 866 were upregulated and 936 gene downregulated. Out of 
the 866 genes upregulated, 270 of these genes were also hypomethylated (Figure 1J, full gene list Suppl. 
File 2B). This equated to 355 different CpG sites on these 270 genes as some individual genes had more 
than one CpG site that was hypomethylated per gene (Suppl. File 2C). Furthermore, out of 936 
downregulated genes there were 216 genes across pooled transcriptome studies that were also 
hypermethylated in the methylome analysis, Figure 1K, Suppl. File 2D). This equated to 268 CpG sites on 
these 216 genes (Suppl. File 2E).  
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Cancer Pathways are Enriched in both the Transcriptome and Methylome Data Sets in Human Skeletal 
Muscle after Acute Resistance Exercise  
KEGG Pathway analysis of the top 20 pathways included 464 genes that were significantly differentially 
regulated (P ≤ 0.01) and significantly enriched (Enrichment P value ≤ 0.003). Out of these 468 genes, 36% 
(168 genes) were in 5 different enriched ‘cancer’ pathways (including; ‘Proteoglycans in cancer’, 
‘Transcriptional misregulation in cancer’, ‘Colorectal cancer’, ‘Small cell lung cancer’, ‘Pathways in cancer’ 
Suppl. File 3A – List of all enriched pathways). Some of the same genes were included across these 
different KEGG cancer pathways, therefore, this related to 106 different cancer genes that were up or down 
regulated after acute RE across all 5 ‘cancer pathways’ (69 cancer genes were upregulated and 37 
downregulated- see below for details). Pathway analysis on the methylome wide data also identified 
‘Proteoglycans in cancer’ and ‘Pathways in cancer’ as significantly enriched (P ≤ 0.001), appearing within 
the top 20 KEGG pathways list after acute RE (Suppl. File 3B – List of all pathways). The visual 
comparison of the pathway diagrams demonstrated that there was a larger proportion of upregulated (green) 
vs. downregulated (red) genes included in ‘Pathways in Cancer’ and ‘Proteoglycans in cancer’ for the 
pooled transcriptome analysis depicted in Figure 2A & 3A (Suppl. Files 3C & 3D respectively). We also 
observed a larger number of hypomethylated (blue) vs. hypermethylated (yellow) CpGs within ‘Pathways in 
Cancer’ and ‘Proteoglycans in cancer’ depicted in Figure 2B and 3B (Suppl. Files 3E & 3F respectively). 
Other than these two cancer pathways, none of the other top 20 enriched pathways in the pooled 
transcriptome gene expression analysis were the same as those identified in the top 20 enriched DNA 
methylation pathways in the methylome analysis (Suppl. File 3A and 3B, respectively). 
 
Out of the genes up (69) and down regulated (37) across these ‘cancer’ pathways (Suppl. File 3G & 3H 
respectively), we then overlapped the genes that were hypo/hypermethylated respectively after acute RE in 
12
 (Figure 4A & B). This analysis identified 23 ‘cancer’ transcripts (Figure 4A; Suppl. File 3I) that were 
upregulated in the pooled transcriptome analysis that also demonstrated significant hypomethylation on the 
same gene following acute RE, this related to 29 CpG sites mapping to the 23 transcripts (as some genes had 
more than 1 CpG site modification per gene). This included genes: MSN, FOS, THBS1, ITPR3, TIMP3, 
RARA, FLNB, LAMA5, RASSF5, CRK, SMAD3, STAT3, COL4A1, ITGA2, WNT9A, ITGB3, KDR, 
ADCY3, CTTN, CD63, DOT1L, F2RL3 and GSK3B (Figure 4A; Suppl. File 3J). The largest proportion 
(57%) of the CpG's were located in a promotor region for the same gene (for at least one their gene 
transcripts; Suppl. File 3J). In skeletal muscle most of these genes (13 out of 23) are associated with matrix / 
actin structure or remodelling and mechano-transduction (MSN, THBS1, TIMP3, FLNB, LAMA5, CRK, 
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COL4A1, ITGA2, ITGB3, CD63, CTTN, RASSF5, F2RL3). With 3 genes associated with TGF- Beta 
signalling (SMAD3, FOS, WNT9A), 2 genes with calcium signalling (ITPR3, ADCY3), and 1 gene with IL-
6 signalling (STAT3), protein synthesis (GSK3B) and retinoic acid signalling (RARA). Finally, after acute 
RE we identified 12 different ‘cancer’ genes (Figure 4B; Suppl. File 3K) that were downregulated in the 
comparative gene expression analysis that were also hypermethylated on 14 CpG sites in the methylome 
analysis 12, (as some genes had more than 1 CpG site modification). This included genes RUNX1T1, GAB1, 
ESR1, LAMA3, NANOG, SMO, ANK3, GADD45G, DROSHA, ATM, APAF1 and AGTR1 (Figure 4B; 
Suppl. File 3K), with varied functions in skeletal muscle (see discussion). Again, the largest proportion 
(64%) of the CpG's were also located in a promotor region for the same gene (for at least one of their gene 
transcripts; Suppl. File 3L). 
 
Pooled Transcriptome Analysis overlapped with the Methylome in Human skeletal Muscle after Chronic 
Resistance Exercise 
A total of 181 biopsy samples made up the pooled chronic RE transcriptome analysis, with 86 (74 after 
outlier removal) baseline (pre) samples and 95 (87 after removal of outliers) post-chronic resistance exercise 
(RE) samples (See Figure 5 legend and Suppl. File 1 for details). These studies shared 15, 317 annotated 
genes by ‘gene symbol’ (Figure 5A). Relevant QA/QC and outlier removal is depicted and described in 
Figure 5B-R and the associated figure legend. From this pooled transcriptome analysis after chronic RE, we 
identified 2,448 genes that were significantly up (2,018 genes) or down (430) regulated (P ≤ 0.01) across all 
studies after chronic RE. Out of these 2,018 upregulated genes, 592 (Suppl. File 4B) were also 
hypomethylated after chronic RE (training/ termed loading in original article) from our methylome-wide 
analysis 12 (Figure 6A; Suppl. File 4B). This equated to 793 different CpG sites mapping to these 592 genes 
(Suppl. File 4C). Furthermore, out of 430 downregulated genes, there were 98 genes across all transcriptome 
studies that were also hypermethylated in the methylome analysis (Figure 6B; Suppl. File. 4D). This equated 
to 132 CpG sites on these 98 genes (Suppl. File 4E). 
 
Identification of significantly enriched KEGG pathways following chronic RE across the transcriptome and 
methylome  
Analysis of the top 20 KEGG pathways significantly enriched in both the pooled transcriptome data sets and 
the methylome data set (Enrichment P values, ≤ 0.009 and ≤ 0.0001, respectively) following chronic RE, 
identified 7 pathways that were shared across both types of genome-wide analyses (Suppl. Files 5A and 5B, 
respectively). These 7 pathways, included: ‘Focal adhesion’, ‘circadian enrichment’, ‘glutamatergic 
synapse’ (Figures 7A-F), ‘phospholipase D signalling’, ‘human papillomavirus infection pathway’(Figure 
8A-D) ‘pathways in cancer’, and ‘proteoglycans in cancer’ (Figures 9A-D) pathways, and displayed a 
greater frequency of upregulated (green) vs. downregulated (red) gene transcripts and a higher number of 
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hypomethylated (blue) vs. hypermethylated (yellow) CpG sites following chronic RE (full gene lists for 
these pathways can be found in Suppl. Files 5C-P).  
 
‘Pathways in cancer’ and ‘Proteoglycans in Cancer’ pathways after chronic RE were also identified in the 
above analysis to be significantly enriched after acute RE at both the transcriptome and methylome level. 
Furthermore, these were the only 2 out of 3 pathways that were in the top 20 enriched pathways identified in 
both acute and chronic RE pooled transcriptome analyses (the only other being the ‘Amoebiasis’ pathway). 
Therefore, as with the acute RE analysis above, we sought to analyse these cancer pathways in more detail 
after chronic RE. Indeed, these 2 cancer pathways combined included a total of 123 cancer related genes, 
108 of which were unique genes (as some were shared/included in both cancer pathways). Out of these 108 
genes that were up/down regulated we identified that 53 of these cancer genes were also modified at the 
DNA methylation level (Figure 10A). Of these 53 genes, this related to 91 different CpG’s (as some genes 
had more than 1 CpG site modification). From these 53 genes, 49 were upregulated (Suppl. File 6A) and we 
identified that 28 of these upregulated genes (Figure 10A; Suppl. File 6B) contained 40 hypomethylated 
CpG sites that mapped to these 28 transcripts, as some genes had more than modified CpG site (Figure 10A; 
Suppl. File 6C). This included genes: COL4A2, HSPG2, MECOM, TGFB3, ITGA6, TCF7L1, TIAM1, 
CTTN, CASP8, GNA12, ADCY4, BCR, PTK2, PLCG2, CCNA1, FN1, LEF1, PLCB4, ITPR1, PLD1, 
TGFBR2, PDCD4, FLNB, PLAUR, HOXD10, HSPB2, CXCL8 and EZR (gene expression and methylation 
fold change of these genes can be seen in Figure 10A; Full lists in Suppl. File 6A & 6B). The largest 
majority (63%) of the CpG's were located in a promotor region for the same gene (for at least one of the 
genes transcripts) (Suppl. File 6C). In skeletal muscle, the predominant function for these genes, as with the 
acute RE analysis above, included ECM/ actin structure and remodelling, mechano-transduction (including 
focal adhesion) and TGF-Beta signalling. Furthermore, 4 out of the original 53 transcripts showed a 
significant down regulation in expression (Suppl. file 6D), with 2 of these transcripts (ZBTB16 and 
MAPK12) displaying a significantly hypermethylated CpG site within the promotor regions of the gene (for 
at least one of their known transcripts) following chronic RE (Figure 10B; Suppl. File 6E for gene 
expression and Suppl. File 6F for methylation).   
 
Epigenetically regulated muscle ‘memory’ genes highlighted in the analysis 
It has been recently identified that following chronic RE training induced hypertrophy a number of CpG 
sites remained hypomethylated during detraining, even when exercise ceased and muscle returned to 
baseline/pre-exercise levels, with this hypomethylation also continuing through to a later period of retraining 
induced muscle hypertrophy 12. We therefore sought to identify if the same genes that were significantly 
regulated in the pooled transcriptome analysis after acute and chronic RE were also identified to be modified 
in the methylome after acute RE, training, detraining and retraining. Indeed, we identified 51 genes that 
were up/downregulated in both the acute and chronic RE transcriptome analysis, (full 51 gene list can be 
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found in Suppl. File 7A&B for acute and chronic gene expression respectively), as well as significantly 
hypo/hypermethylated after acute RE (Suppl. File 7C), training/ loading (Suppl. File 7D), 
detraining/unloading (Suppl. File 7E) and retraining/reloading (Suppl. File 7F). All 51 genes were 
significantly differentially regulated and epigenetically modified in every condition on at least one of their 
CpG sites. However, because there was more than one CpG site per gene for several genes, there were only 
13 of the same CpG sites (corresponding to 13 different gene transcripts) that were significantly modified 
across all methylation time points (acute RE, loading/training, unloading/detraining, retraining/reloading) 
and gene expression time points (acute/chronic RE). This included genes: FLNB, ASAP1, HMCN1, KDR, 
MBP, MYH9, MYH10, NDEL1, SRGAP1, SRGN, UBTF, ZMIZ1. From this we identified 5 CpG’s on 5 
genes including: FLNB, MYH9, SRGAP1, SRGN, ZMIZ1 (with MYH9, SRGAP1, SRGN being promoter 
associated for at least one of their associated genes transcripts) with increased gene expression in both the 
transcriptome analysis after both acute and chronic RE and also demonstrated hypomethylation in these 
conditions (Figure 11 A-E respectively). Further analysis of the methylome-wide data set, demonstrated 
retained hypomethylation in these CpG sites across detraining and retraining time points (Figure 11 A-E).  
This retained epigenetic modification is most interesting following detraining (after training induced 
hypertrophy), when exercise was completely ceased and lean mass returned to baseline (pre-training) levels 
(reported previously 12), as this temporal regulation was demonstrated in 12 and proposed to identify those 
genes that have an epigenetic memory or prior exercise induced hypertrophy.  
 
Finally, Filamin B (FLNB) was identified in the ‘cancer’ pathway (with a role in the actin cytoskeleton) in 
both acute RE and chronic RE transcriptomic analysis above, as well identified in the 51 genes significantly 
modified across transcriptome and methylome analysis, and further identified in the final 5 genes above with 
increased gene expression as well as hypomethylation (with retained methylation during detaining and 
retraining). Therefore, we undertook new analysis of the mRNA expression of this gene in samples derived 
from 12, after acute and chronic RE, detaining and retraining. Indeed, we identified that gene expression of 
FLNB was significantly increased after acute RE (1.54 fold ± 0.1 SEM vs. pre/baseline P = 0.01). The 
average fold change in FLNB was also increased after chronic RE (training) (1.27 fold ± 0.2 SEM vs. 
pre/baseline) and remained elevated vs. baseline after detraining (unloading) (1.38 fold ± 0.37 SEM vs. 
pre/baseline) and retraining (reloading) (1.38 fold ± 0.5 SEM vs. pre/baseline) (Figure 12). However, these 
increases failed to reach statistical significance. Yet, this did demonstrate and inverse relationship with DNA 
methylation (hypomethylation after acute RE that was sustained throughout training, detraining and 
retraining, Figure 12). 
 
Discussion 
 
In the present study we undertook bioinformatic analysis and identified significantly up and down regulated 
genes across publicly available transcriptome studies after acute and chronic resistance exercise in human 
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skeletal muscle. We then overlapped this with recent data that measured the DNA methylome response after 
acute resistance exercise (acute RE), chronic RE (loading/training), detraining (unloading) and retaining 
(reloading)12. We had the specific aim to identify novel genes/gene expression pathways that were 
epigenetically regulated at the DNA methylation level after acute anabolic exercise, chronic resistance 
exercise induced hypertrophy and those associated with an epigenetic memory.  
 
 
 
KEGG Cancer Pathways are Significantly enriched in the Transcriptome and Methylome after Acute RE 
which are associated with ECM/ Actin Structure, Remodelling and Mechano-transduction in Human 
Skeletal Muscle.   
After acute RE we identified 866 up- and 936 down-regulated genes, with 270 (out of the 866 up-regulated) 
identified as being hypomethylated, and 216 (out of 936 downregulated) as hypermethylated. After KEGG 
pathway analysis, genes associated with several ‘cancer’ pathways were significantly enriched in both the 
pooled transcriptome analysis and also enriched in the methylome data after acute RE. This resulted in 23 
upregulated and 12 downregulated ‘cancer’ genes that were also hypo/ hypermethylated, respectively. The 
largest proportion of the CpG sites (57%) on these ‘cancer’ associated genes were promoter associated. 
Modification of site specific methylation in the promotor region of coding gene sequences is known to be an 
important regulator of the down-stream expression of the transcript, largely due to manipulation of binding 
and accessibility of polymerase apparatus 11. We therefore identified an important role for DNA methylation 
in the promoter regions of genes within human skeletal muscle after acute RE, adding to previous work with 
similar findings in endurance exercise 24. Of these 35 ‘cancer’ genes, 23 were upregulated and 
hypomethylated, with a large proportion of these genes (13 out of 23) known to be important in matrix / 
actin structure and remodelling as well as mechano-transduction in skeletal muscle including: MSN, 
THBS1, TIMP3, FLNB, LAMA5, CRK, COL4A1, ITGA2, ITGB3, CD63, CTTN, RASSF5, F2RL3 (full 
gene names and general function is included in Suppl. File 8). Importantly, some of these ECM/actin 
structural and remodelling genes have been shown to demonstrate increases after aerobic or resistance 
exercise at the gene expression, protein abundance or activity level such as; TIMP3 25, FLNB 26, COL4A1 
27,28
, or are involved in satellite/muscle cell regulation (ITGB3 29, CTTN 30, LAMA5 31, CRK 32,33). However, 
to the authors knowledge there is no evidence to suggest that any of these genes are differentially methylated 
at the DNA level in skeletal muscle anabolism or hypertrophy. Therefore, the present study demonstrates for 
the first time, that important skeletal muscle genes/ gene pathways are also epigenetically regulated via 
DNA methylation, and that this predominantly occurs via the hypomethylation and upregulation of genes 
associated with structure and remodelling of the matrix and cytoskeleton as well as mechano-transduction in 
skeletal muscle.  
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It is also worth noting that a further 10 genes after acute RE were significantly differentially regulated and 
enriched in ‘cancer’ pathways within both the transcriptome (upregulated) and methylome (hypomethylated) 
analysis, and included 3 genes associated with TGF-beta signalling (FOS, SMAD3, WNT9A), 2 genes with 
calcium signalling (ITPR, ADCY) and 1 gene with IL-6 signalling (STAT3), protein synthesis (GSK3B) and 
retinoic acid signalling (RARA). TGF-Beta signalling is a major growth regulator, and has been 
demonstrated to be important in skeletal muscle mass regulation and exercise adaptation. Indeed, we 
demonstrate increased expression and hypomethylation of FOS (or c-FOS) downstream of TGF-Beta, 
previously highlighted to be upregulated at the gene expression level after 30 minutes running 34 and after 
resistance exercise in rats 35, as well as post 2 hrs RE in humans 36. We also demonstrated increased 
expression/hypomethylation of SMAD3 (intracellular signal transducer and transcriptional modulator), 
known to be activated by TGF-beta and activin type 1 receptor kinases 37. However, in opposition with the 
current data, SMAD3 is increased in atrophy where muscle-specific knock-down of Smad2/3 in rodents 
protects from muscle atrophy following denervation 38. Yet, in support of the present study, it has recently 
been demonstrated that SMAD/JNK axis is important for muscle size regulation after resistance exercise, 
but not after aerobic exercise 39. Also, associated with TGF-Beta, the gene WNT9A was hypomethylated 
and upregulated, where it functions in the canonical Wnt/beta-catenin signalling pathway and has been 
identified, together with TGF-Beta2 and FGFR4, to be a key gene for the differentiation of muscle satellite 
cells 40. The calcium signalling genes that were upregulated and hypomethylated included; ITPR3 (or IP3R 
3 - Inositol 1,4,5-trisphosphate receptor type/isoform 3) that has been associated with Ca2+ signals leading 
to gene regulation in skeletal muscle cells that contribute to muscle fibre growth and NMJ stabilization 41. 
While ADCY3 has no clearly defined role in skeletal muscle, it catalyzes the formation of the signalling 
molecule cAMP in response to G-protein signalling 42, and regulates Ca2+-dependent insulin secretion. Its 
methylation has been demonstrated to change in adipose tissue in response to altered nutrition 43, but no 
methylation data currently exists in skeletal muscle.  
 
We also demonstrate increases in gene expression and hypomethylation of other important genes in muscle; 
STAT 3, GSK3B and RARA. Indeed, STAT3 is downstream of IL-6, and is known to play a critical role in 
regulating skeletal muscle mass, repair and is associated with myopathy (recently reviewed here 44). 
However, while it has been shown to have increased protein activity after resistance exercise 45, recent 
studies have shown that it is not required for overload induced hypertrophy in rodents 46. The important 
protein synthesis regulator, GSK3B (Glycogen synthase kinase-3 beta), regulates protein synthesis by 
controlling the activity of initiation factor 2B (EIF2BE/EIF2B5), and has previously been shown to increase 
after resistance exercise and decrease during skeletal muscle atrophy 47. Finally, RARA (Retinoic acid 
receptor alpha), important in skeletal muscle repair and satellite cell self-renewal 47 48, is also upregulated and 
hypomethylated.  Once again, to the authors knowledge there is no previous evidence to suggest that any of 
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these transcripts are differentially methylated in skeletal muscle anabolism or hypertrophy. Further 
demonstrating the potential role DNA methylation plays in modulating the anabolic response of skeletal 
muscle mass after acute RE.  
 
Of the above 35 ‘cancer’ genes up/downregulated after acute RE, we also demonstrated that 12 were 
downregulated and hypermethylated, including: RUNX1T1, GAB1, ESR1, LAMA3, NANOG, SMO, 
ANK3, GADD45G, DROSHA, ATM, APAF1 and AGTR1. These genes related to several different 
functions within skeletal muscle and with the exception of those relating to apoptosis (GADD45G, ATM, 
APAF1), display very limited connection to one-another. Most notably for skeletal muscle, however, ESR1 
(estrogen receptor 1) in the present study was hypermethylated with reduced gene expression in the young 
adult males after acute RE, whereas in female mice after knock-down, it has been shown to cause muscle 
weakness 49 yet, overexpression can result in a slow muscle fibre phenotype 50. Therefore, a reduction 
observed in the adult males may therefore be associated with reduced slow fibre formation and subsequently 
may be conducive to faster fibre formation, previously identified to occur after resistance exercise. The 
association of hypermethylated and downregulation of ESR1 and its role in fibre type transition requires 
further investigation. 
 
KEGG Cancer Pathways are Significantly enriched after Chronic RE in the Transcriptome and Methylome 
and associated with ECM/ Actin Structure and Remodelling, Mechano-Transduction and Focal Adhesion in 
Human Skeletal Muscle.   
After chronic RE we identified 2,018 up- and 430 down-regulated genes with 592 (out of 2018 upregulated) 
identified as being hypomethylated, and 98 (out of 430 genes downregulated) as hypermethylated. As with 
the acute RE analysis above, KEGG pathway analysis identified both ‘Pathways in cancer’ and 
‘Proteoglycans in cancer’ to be significantly enriched in both the pooled transcriptome data and methylome 
data. Furthermore, these were the 2 predominant pathways identified in both the acute and chronic 
transcriptome analysis.  After chronic RE, 28 (out of 49 upregulated) and 2 (out of 4 down-regulated) 
‘cancer’ genes were also hypomethylated/hypermethylated respectively. In conjunction with the acute RE 
data, the largest proportion (63%) of the CpG sites on these KEGG ‘cancer’ genes were promoter 
associated. This included: COL4A2, HSPG2, MECOM, TGFB3, ITGA6, TCF7L1, TIAM1, CTTN, CASP8, 
GNA12, ADCY4, BCR, PTK2, PLCG2, CCNA1, FN1, LEF1, PLCB4, ITPR1, PLD1, TGFBR2, PDCD4, 
FLNB, PLAUR, HOXD10, HSPB2, CXCL8 and EZR. Out of the 28 genes upregulated, a large proportion 
of the genes (14 out of 28) as with the acute RE analysis above, where associated with ECM/ actin structure 
and remodelling, mechano-transduction as well as focal adhesion in skeletal muscle including: COL4A2, 
HSPG2, TIAM1, CTTN, ADCY4, BCR, PTK2 aka. FAK, PLCG2, FN1, PLD-1, FLNB, EZR (for list of full 
gene name and broad function see Suppl. File 8). In terms of their role in skeletal muscle and exercise 
induced hypertrophy, only 7 out of these 14 upregulated and hypomethylated genes have been investigated, 
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notably COL4A2, HSPG2, TIAM1, CTTN, PTK2/FAK, PLD1 and PLAUR. Indeed, the responsiveness of 
COL4A2 (Type IV collagen) to muscle unloading and reloading seems to be impaired in aged muscle of rats 
28
. Further, HSPG2 (Perlecan) has been identified to alter mass and metabolism in skeletal muscle 51. 
TIAM1 has been associated with skeletal muscle glucose uptake 52. CTTN (cortactin) contributes to the 
organization of the actin cytoskeleton 53 and is also important in actin filament remodelling in L6 myotubes 
30
. The abundance of FN1 (fibronectin) is blunted in elderly human skeletal muscle following muscle 
damage evoked via eccentric muscle contraction, compared to young healthy controls 54. PLAUR acts as a 
receptor for urokinase plasminogen (uPA) with uPA-null mice demonstrating a complete lack of 
hypertrophy in response to synergistic ablation 55. Also, while there are limited studies for the role of FLNB 
(filamin B) in skeletal muscle or resistance exercise induced hypertrophy, its loss has recently been 
highlighted to be associated with several myopathies and therefore a potential interesting target in skeletal 
muscle adaptation 26. Further, its closely related genes/protein family members, such as filamin A (FLNA) 
have been identified as a substrate of Akt and phosphorylated after endurance exercise, but not resistance 
exercise 56, and filamin C (FLNC) has been demonstrated to be closely associated with autophagy processes 
after resistance exercise 57. These findings therefore suggest FLNB requires further attention as to its role in 
skeletal muscle anabolism and hypertrophy.  
 
Most interestingly in this group of identified hypomethylated and upregulated genes, PTK2 (Focal adhesion 
kinase/FAK) has been previously identified as an important regulator of mechanical loading in skeletal 
muscle, as it is predominantly located within the costamere (a mechano-sensory site of focal adhesion in the 
sarcolemma). FAK increases at the protein activity level after resistance exercise in human skeletal muscle, 
with its increased activation elevated to the largest extent after eccentric contraction 58. Furthermore, 
overexpression of FAK can have a protective effect on skeletal muscle reperfusion injury after limb 
ischemia 59, and increasing FAK can also increase the β1-integrin and meta-vinculin (+88%) content in 
skeletal muscle 60. PLD-1 is another major mechano-sensor that has been explicitly linked with numerous 
functions in skeletal muscle, where it has been shown to be fundamental for muscle cell differentiation 61 , 
as well as myotube size via the activation of mechanistic target of rapamycin (mTOR) 62. Importantly in 
rodents, the activation of mTOR following eccentric lengthening contractions occurs through a PI3K-PKB-
independent mechanism, a process that requires upstream PLD and phosphatidic acid 63.  
 
The remaining genes in the 28 ‘cancer’ genes identified as upregulated and hypomethylated, as with the 
acute RE analysis, this included genes implicated in TGF-beta signalling (TGFB3, TGFBR2, LEF1 and 
MECOM) after chronic RE in human skeletal muscle. These associated transcripts included: TGFB3 
(Transforming growth factor beta-3) itself, TGF-beta receptor type-2 (TGFBR2) a receptor for the TGF-beta 
ligands TGFB1, TGFB2 & TGFB3 as well as; LEF1, that is associated with WNT-TCF/LEF and TGF-Beta-
SMAD3 signalling in controlling muscle stem cell proliferation and self-renewal 64. Finally, MECOM (alias 
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EVI-1) has been demonstrated to play a role in growth regulation via TGF-beta/SMAD signalling65. 
However, to the authors knowledge, MECOM has not been studied specifically in skeletal muscle anabolism 
or hypertrophy.  
 
Collectively, we identify important epigenetically regulated ‘cancer’ genes that are associated with 
ECM/Actin structure and remodelling, mechano-transduction/focal adhesion (e.g. FAK and PLD) and TGF-
Beta signalling after chronic RE in human skeletal muscle. While these were also the gene pathways 
associated with acute RE analysis above, it is worth noting that only two of the same genes, CTTN and 
FLNB were increased and hypomethylated after both acute and chronic resistance exercise analysis, and 
there were no other genes that were downregulated and hypermethylated that appeared in both acute and 
chronic transcriptome analysis. This suggested that while ‘cancer’ pathways, important in skeletal muscle 
matrix/ actin structure and remodelling, mechano-transduction and TGF-Beta signalling were important 
after both acute and chronic resistance exercise, the longer-term adaption to chronic exercise seems to be 
regulated by different genes within the same pathways versus a single bout of resistance exercise.  
 
Newly Identified Epigenetic Memory Genes in Human Skeletal Muscle 
51 genes were identified to be up/downregulated in both the acute and chronic RE transcriptomic analysis as 
well as significantly hypo/hypermethylated after acute RE, chronic RE, detraining and retraining. Five genes 
(MYH9, SRGAP1, SRGN, ZMIZ1, FLNB) demonstrated increased gene expression in the acute and chronic 
RE transcriptome while also demonstrating hypomethylation in these conditions. Importantly, these 5 genes 
also retained hypomethylation even during detraining (following training induced hypertrophy) when 
exercise completely cessed and lean mass returned to baseline (pre-training) levels. We therefore suggest, 
given the retention of epigenetic information within CpG sites of these transcripts, that these may be newly 
identified memory genes that warrant further investigation. Interestingly MYH9, while it has been shown to 
be expressed at the gene level in skeletal muscle tissue, it is not thought to be translated into the protein and 
is therefore classed as a non-muscle myosin heavy chain. Therefore, it could be hypothesised that its 
hypomethylation and increased gene expression has other, yet undescribed, post-transcriptional functions in 
skeletal muscle anabolism and hypertrophy. SRGAP1 is a GTPase-activating protein for RhoA and Cdc42 
small GTPases 66,67 and therefore, while potentially important in mechano-transduction, has not been studied 
in skeletal muscle. Serglycin (SRGN) is a proteoglycan that has been shown to increase its expression after 
acute and chronic aerobic exercise in humans, with cultured human muscle derived cells both expressing 
and secreting serglycin68. However, to the authors knowledge SRGN has not been studied after resistance 
exercise at either the gene expression of DNA methylation level, yet we identify it as a potential gene 
involved in epigenetic muscle memory. ZMIZ1 is a transcriptional co-activator that modules the 
transcription of androgen receptor (AR), SMAD3/4, and p53 in other cell types 69-71. However, its role in 
skeletal muscle is yet undefined. Intriguingly, AR, SMAD and p53 are all important regulators of skeletal 
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muscle mass and metabolism and therefore this gene requires further investigation as to its epigenetic role in 
skeletal muscle.  
 
Finally, Filamin B (FLNB) was also identified in the gene expression and methylation analysis in both acute 
and chronic pooled transcriptome data and was significantly enriched in ‘cancer pathways’ in both the 
pooled transcriptome and methylome. At the protein level filamin B is involved in connecting the cell 
membrane constituents to the actin cytoskeleton, where mutations of the gene are inextricably linked to 
several myopathies 26. From an exercise-induced response/adaptation perspective, there is limited 
information regarding the role of Filamin B in skeletal muscle following RE. Interestingly, Filamin A 
(protein family member) has been shown to be a substrate of Akt, and to be phosphorylated after endurance 
exercise, but not after resistance exercise 56. More so, Filamin C has been shown to be altered following RE, 
and is closely associated with autophagy processes altered after resistance exercise 57. Experimentally, we 
were able to confirm that Filamin B was increased at the gene expression level after acute and chronic RE 
and remained elevated (but non-significantly) after detraining and retraining where the gene remained as 
hypomethylated even during exercise cessation (detraining). However, increases in FLNB were only 
significant after acute RE. Despite this, and given the associated sustained hypomethylation, we suggest that 
this gene requires further mechanistic investigation as to its role in skeletal muscle anabolism, hypertrophy 
and memory. 
 
Conclusion 
Importantly, for the first time across both the transcriptome and methylome, this study identifies novel 
epigenetically regulated genes with predominant roles in human skeletal muscle ECM/ actin structure and 
remodelling, mechano-transduction as well as TGF-beta signalling associated with anabolism, hypertrophy 
and memory. 
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Figure Legends 
 
Figure 1:  A: Venn diagram analysis identified a shared list of 14,992 annotated genes by ‘gene symbol’ 
across the pooled transcriptomic studies for acute RE. Note 4,5 use the same gene array platform but the 
number of genes is depicted as different. This is due to the highest probe set analysis (see methods) altering 
the genes that could be compared in this study. Inspecting B, box and whisker plots before batch correction 
and, C, frequency plots by lines there was a noticeable signal/ value variation as a result of batch effects 
across studies. D, Box and Whisker plots post batch correction and E, frequency normalisation plots by lines 
post batch correction. F, PCA post batch correction by time (pre/post) and G: PCA by study depicting the 
outliers removed (line strikethrough) that were located outside 2SD’s of the centroid value using ellipsoids. 
H, Sample box and whiskers plot with batch correction and outlier samples (highlighted in F/G) removed. I, 
Frequency Plot by Lines after batch correction and with outlier samples (highlighted in F/E) removed. J, 
Venn Diagram demonstrating out of 866 genes upregulated after acute RE (p ≤ 0.01) in the pooled 
transcriptomic analysis, 270 of these genes were significantly hypomethylated in the methylome analysis 12. 
K, Venn Diagram demonstrating out of 936 genes downregulated after acute RE (p ≤ 0.01) in the pooled 
transcriptomic analysis, 216 of these genes were significantly hypermethylated in the methylome analysis 12. 
Note: 5752 / 4604 total hypo/hypermethylated CpGs after acute RE is different than the original paper 
reporting 9,153 / 8,212 hypo/hypermethylated CpGs. This is due to the number of CpG’s that resided on the 
shared list of 14,992 annotated genes by ‘gene symbol’ across the pooled transcriptomic studies for acute 
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RE, depicted above in 1A, in order to provide a direct comparison of CpG sites on the same genes from the 
pooled transcriptomic data set.  
 
Figure 2: KEGG ‘Pathways in Cancer’ pathway diagram, significantly enriched in both pooled 
transcriptome and methylome data sets after acute RE. A, Gene expression from pooled transcriptomic data 
set after acute RE. Green = Upregulated, Red = Downregulated. B, CpG DNA methylation from 12. Blue = 
Hypomethylated, Yellow = Hypermethylated. Note in figure B where individuals genes with multiple CpGs 
are differentially methylated, Partek Pathway (Partek Genomics Suite) chooses the CpG with the highest 
significance (lowest p-value) and uses the fold-change for that CpG to colour the pathway diagram. 
Therefore, B is for a visual representation of the majority of genes in this pathway becoming 
hypomethylated (more genes highlighted as blue). However, this may misrepresent an individual CpG site 
where the gene may have CpG’s that are both hypo and hypermethylated. Therefore, please also see Suppl. 
File 3E for the full KEGG ‘Pathways in Cancer’ gene list used to create the pathway diagram.  
 
Figure 3: KEGG ‘Proteoglycans in cancer’ pathway diagram, significantly enriched in both pooled 
transcriptome and methylome data sets after acute RE. A, Gene expression from pooled transcriptomic data 
set after acute RE. Green = Upregulated, Red = Downregulated. B, DNA/CpG methylome data after acute 
RE 12. Blue = Hypomethylated, Yellow = Hypermethylated. Note in B, where individuals genes with 
multiple CpGs are differentially methylated, Partek Pathway (Partek Genomics Suite) chooses the CpG with 
the highest significance (lowest p-value) and uses the fold-change for that CpG to colour the pathway 
diagram. Therefore, B is for a visual representation of the majority of genes in this pathway becoming 
hypomethylated (more genes highlighted as blue). However, this may misrepresent an individual CpG site 
where the gene may have CpG’s that are both hypo and hypermethylated. Therefore, please also see Suppl. 
File 3F for the full KEGG ‘Proteoglycans in cancer’ gene list used to create the pathway diagram.  
 
Figure 4: A, ‘Cancer’ pathway genes upregulated (GREEN bars) in pooled transcriptomic studies and 
hypomethylated (BLUE bars) in 12 after acute RE. In skeletal muscle, the majority of these genes (13 out of 
23) are associated with matrix / actin structure or remodelling and mechano-transduction in skeletal muscle 
(MSN THBS1, TIMP3, FLNB, LAMA5, CRK, COL4A1, ITGA2, ITGB3, CD63, CTTN, RASSF5, F2RL3) 
and 3 genes with TGF- Beta signalling (SMAD3, FOS, WNT9A), 2 genes with calcium signalling (ITPR3, 
ADCY3), 1 gene with IL-6 signalling (STAT3), and protein synthesis (GSK3B) and retinoic acid signalling 
(RARA). B, ‘Cancer’ genes downregulated (RED) in pooled transcriptomic studies and hypermethylated 
(YELLOW bars) in after acute RE 12. 
 
Figure 5: A, Venn diagram analysis identified a shared list of 15,317 annotated genes by ‘gene symbol’ 
across the pooled transcriptomic studies for chronic RE. B, PCA for study and C, time (pre / post) D, box 
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and whisker plots by study and E, by time point. F, frequency/density plots by lines for study and G time 
(pre/post). There was noticeable signal/ value variation as a result of batch effects across studies. Following 
batch correction: H, PCA by time and I, by study demonstrated smaller variation than prior to batch 
correction (B & C above). J Box and whisker plots by study and K, by time post batch removal. L, 
Frequency plots by time and M, by study post batch removal demonstrated more appropriate signals and 
distribution compared with those prior to batch removal (D-G). N, PCA post batch correction by time 
(pre/post) depicting the outliers removed (line strikethrough) that were located outside 2SD’s of the centroid 
value using ellipsoids. O, Frequency/density plots by time and P, by study post batch removal with outliers 
(identified in N) removed. Q, Box and whisker plots by time and R, by study post batch removal with 
outliers (identified in N) removed.  
 
Figure 6: A, Venn Diagram analysis demonstrating out of 2,018 genes upregulated after chronic RE (p ≤ 
0.01) in the pooled transcriptomic analysis, 592 of these genes were significantly hypomethylated in the 
methylome analysis after chronic RE12. B, Venn Diagram demonstrating out of 430 genes downregulated 
after chronic RE (p ≤ 0.01) in the pooled transcriptomic analysis, 98 of these genes were significantly 
hypermethylated in the methyome analysis after chronic RE 12. Note: 5262 / 4853 total 
hypo/hypermethylated CpGs after chronic RE is different than the original paper reporting 8,891 / 8,636 
hypo/hypermethylated CpGs 12. This is due to the number of CpG’s that resided on the shared list of 15,317 
annotated genes by ‘gene symbol’ across the pooled transcriptomic studies for chronic RE, depicted above 
in 5A, in order to provide a direct comparison of CpG sites on the same genes from the pooled 
transcriptomic data set. 
 
Figure 7: Enriched KEGG pathways in both pooled transcriptome and methylome after chronic RE. A, 
‘Focal Adhesion’ Gene expression, B, ‘Focal Adhesion’ DNA Methylation, C, ‘Circadian Entrainment’ 
Gene expression, D, ‘Circadian Entrainment’ DNA Methylation, E, ‘Glutamatergic Synapse’ Gene 
expression, F, ‘Glutamatergic Synapse’ DNA Methylation. For gene expression figures (A, C, E), Green = 
Upregulated, Red = Downregulated. For DNA methylation figures (B, D, F), Blue = Hypomethylated, 
Yellow, Hypermethylated. Note in B, D & F where individuals genes with multiple CpGs are differentially 
methylated, Partek Pathway (Partek Genomics Suite) chooses the CpG with the highest significance (lowest 
p-value) and uses the fold-change for that CpG to colour the pathway diagram. Therefore, B, D & F are for 
visual representation of the majority of genes in these pathways becoming hypomethylated (more genes 
highlighted in blue). However, this may misrepresent an individual CpG site where the gene may have 
CpG’s that are both hypo and hypermethylated. Therefore, please also see Suppl. File 5D, F & H for the full 
KEGG gene list used to create the pathway diagrams in B, D & F.  
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Figure 8: Enriched KEGG pathways in both pooled transcriptome and methylome analysis after chronic RE. 
A, ‘Phospholipase-D signaling’ Gene expression, B, ‘Phospholipase-D signaling’ DNA methylation, C, 
‘Human Papillomavirus Infection Pathways’ Gene Expression, D, ‘Human Papillomavirus Infection 
Pathways’ DNA methylation. For gene expression figures (A, C) Green = Upregulated, Red = 
Downregulated. For DNA methylation figures (B, D) Blue = Hypomethylated, Yellow, Hypermethylated. 
Note in B & D Where individuals genes with multiple CpGs are differentially methylated, Partek Pathway 
(Partek Genomics Suite) chooses the CpG with the highest significance (lowest p-value) and uses the fold-
change for that CpG to colour the pathway diagram. Therefore, B & D are for visual representation for the 
majority of genes in these pathways becoming hypomethylated (more blue genes). However, this may 
misrepresent an individual CpG site where the gene may have CpG’s that are both hypo and 
hypermethylated. Therefore, please also see Suppl. File 5 J & L for the full KEGG gene list used to create 
the pathway diagrams in B, D.   
 
Figure 9. Enriched KEGG pathways in both pooled transcriptome and methylome analysis after chronic RE. 
A, ‘Pathways in cancer’ gene expression, B, ‘Pathways in cancer’ DNA methylation, C, ‘Proteoglycans in 
cancer’ gene Expression, D, ‘Proteoglycans in cancer’ DNA methylation. For gene expression figures (A, C) 
Green = Upregulated, Red = Downregulated. For DNA methylation figures (B, D) Blue = Hypomethylated, 
Yellow, Hypermethylated. Note in B & D Where individuals genes with multiple CpGs are differentially 
methylated, Partek Pathway (Partek Genomics Suite) chooses the CpG with the highest significance (lowest 
p-value) and uses the fold-change for that CpG to colour the pathway diagram. Therefore, B & D are for 
visual representation of the majority of genes in these pathways becoming hypomethylated (more blue 
genes). However, this may misrepresent an individual CpG site where the gene may have CpG’s that are 
both hypo and hypermethylated. Therefore, please also see Suppl. File 5N & P for the full KEGG gene list 
used to create the pathway diagrams in B, D.   
 
Figure 10: A, ‘Cancer’ genes upregulated (GREEN bars) in pooled transcriptome studies and 
hypomethylated (BLUE bars) in methylome analysis after chronic RE 12. In skeletal muscle, the majority of 
these genes are associated with matrix and actin structure / remodelling COL4A2, HSPG2, ITGA6, TIAM1, 
CTTN, GNA12, ADCY4, BCR, PLCG2, FN1, FLNB, PLAUR, EZR), mechano-transduction (PTK2/FAK 
and PLD1) and TGF-Beta signalling (TGFB3, TGFBR2, LEF1, MECOM). B, ‘Cancer’ genes 
downregulated (RED) in pooled transcriptomic studies and hypermethylated (YELLOW bars) in methylome 
analysis after chronic RE 12.  
 
Figure 11: Fold change in gene expression (normalised to 0) from pooled transcriptome analysis after acute 
and chronic RE and methylome analysis after acute and chronic RE, detraining and retraining. A; MYH9, B; 
SRGAP1, C; SRGN, D; ZMIZ1 and E; FLNB demonstrated increased gene expression in both the 
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transcriptome analysis after both acute and chronic RE and also demonstrated hypomethylation in these 
conditions in the methylome analysis. Importantly, these genes also demonstrated retained hypomethylation 
even during detraining (following training induced hypertrophy) when exercise was completely cessed and 
lean mass in the original study 12 returned to baseline (pre-training) levels.  
 
Figure 12: New analysis of FLNB gene expression via rt-qRT-PCR demonstrated that the gene significantly 
increased in expression after acute RE vs. pre/baseline (P = 0.01). The average fold change in FLNB was 
also increased after chronic RE (training) and remained elevated vs. pre/baseline after detraining (unloading) 
and retraining (reloading) However, these increases failed to reach statistical significance. In the methylation 
array data FLNB methylation demonstrated an inverse association with the gene expression where the gene 
was hypomethlyated after acute and chronic RE, with sustained hypomethylation during detraining and 
retraining.  
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